Skip to the page

Data / Form D filings / Haro Pharmaceutical, Inc.

Haro Pharmaceutical, Inc.: Form D filing

Haro Pharmaceutical, Inc., a biotechnology company in Merion Station, PA, filed a Form D with the SEC in 2011. The latest, on January 10, 2011, reports $50,000 sold of a $1 million offering to 1 investor.

Find out what Haro Pharmaceutical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
554 MANAYUNK ROAD, Merion Station, PA, 19066
Phone
(610) 348-3245
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Pennsylvania
Year incorporated
2010
Revenue range
No Revenues
Exemptions claimed
Rule 506
SEC identifier (CIK)
1508979

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 10, 2011New notice$1,000,000$50,000$950,0001Dec 30, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Guy ShitritExecutive Officer, Director
David BettounExecutive Officer, Director

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Jan 10, 2011 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Haro Pharmaceutical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.